Page last updated: 2024-09-05

prolyl-phenylalanyl-arginine-4-methylcoumaryl-7-amide and Autoimmune Disease

prolyl-phenylalanyl-arginine-4-methylcoumaryl-7-amide has been researched along with Autoimmune Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bangale, Y; Kalaga, R; Karle, S; Li, L; Nishiyama, Y; Paul, S; Planque, S; Taguchi, H; Zhou, YX1

Other Studies

1 other study(ies) available for prolyl-phenylalanyl-arginine-4-methylcoumaryl-7-amide and Autoimmune Disease

ArticleYear
VIPase autoantibodies in Fas-defective mice and patients with autoimmune disease.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2003, Volume: 17, Issue:6

    Topics: Animals; Autoantibodies; Autoimmune Diseases; Catalysis; Cloning, Molecular; fas Receptor; Humans; Hydrolysis; Immunoglobulin Fragments; Immunoglobulin G; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Molecular Sequence Data; Mutation; Oligopeptides; Thyroglobulin; Thyroiditis, Autoimmune; Vasoactive Intestinal Peptide

2003